| Green Tea (Camellia sinensis) and Olive (Olea europaea L.) Leaf Extracts for Cancer Chemoprevention: The Tumor Suppressor p53 as a Potential Molecular Target (EACR23-0591) |
|
2023 |
| Mutant p53 promotes tumor progression through its transmission between tumor cells in a prion-like manner (EACR23-1290) |
|
2023 |
| PRIMA-1 inhibits amyloid aggregation of mutant p53 in cancer cells |
|
2019 |
| Vitamin K-derived compounds with promising effects against mutant p53 aggregation |
|
2019 |
| Resveratrol prevents p53 aggregation in vitro and in vivo |
|
2019 |
| Resveratrol prevents p53 aggregation in vitro and in vivo |
|
2018 |
| EFFECTS OF MICHAEL ACCEPTORS COMPOUNDS ON P53 AGGREGATION IN BREAST AND OVARIAN CANCER CELLS |
|
2018 |
| ADVANCES ON THE STUDY OF P53 AGGREGATION USING ANTI-AMYLOID COMPOUNDS |
|
2017 |
| RESVERATROL PREVENTS p53 AGGREGATION IN VITRO AND IN BREAST CANCER CELLS |
|
2017 |
| Effects of Prima-1 and Michael Aceptors on Mutant p53 Aggregation |
|
2017 |
| ON THE SEARCH FOR MUTANT P53 ACTIVATORS ON HEPATOCELLULAR CARCINOMA |
|
2017 |
| EMPLOYING ANTI-AMYLOID COMPOUNDS FOR UNDERSTANDING OF THE AGGREGATION OF TUMOR SUPPRESSOR PROTEIN P53 |
|
2017 |
| EFFECTS OF PRIMA-1 AND MICHAEL ACEPTORS ON MUTANT P53 AGGREGATION |
|
2017 |
| Resveratrol prevents p53 agregation in vitro and in breast cancer cells |
|
2017 |
| The p53 anti-aggregation effect of PRIMA-1 |
|
2017 |
| PRIMA-1 REACTIVATES MUTANT P53 THROUGH THE MOBILIZATION OF ITS AGGREGATED FRACTION IN THE CELL |
|
2016 |
| THE ROLE OF CHAPERONES ON MUTANT P53 AGGREGATION |
|
2016 |
| RESVERATROL AND ITS STRUCTURAL ANALOGUES AS POTENTIAL INHIBITORS OF P53 PROTEIN AGGREGATION |
|
2016 |
| P53 AGGREGATION IN HEPATOCELLULAR CARCINOMA CELL LINES |
|
2016 |
| BIOCHEMICAL AND BIOPHYSICAL STUDIES OF THE INTERACTION BETWEEN HEPATITIS C VIRUS CORE PROTEIN AND P53 |
|
2016 |
| Anti-amyloid compounds as new p53 aggregation inhibitors and cell sensitizers to cancer chemotherapy |
|
2015 |
| RNA-seq analysis reveals the relevance of ribosomal RNAs to Induce Recombinant Mouse Prion Protein Aggregation and Toxicity in vitro |
|
2015 |
| STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE HEPATITIS C VIRUS CORE PROTEIN AND ITS INTERACTION WITH THE TUMOR SUPRESSOR PROTEIN p53 |
|
2015 |
| The p53 reactivator PRIMA-1 inhibits p53 aggregation |
|
2015 |
| POTENTIAL ROLE OF RESVERATROL AND ITS STRUCTURAL ANALOGS IN PREVENTING p53 TUMOR SUPPRESSOR PROTEIN AGGREGATION |
|
2015 |
| Understanding the p53 Aggregation Process through its Activators Resveratrol and PRIMA-1 |
|
2015 |
| p53 Aggregation and prionoid effect and the modulation of this process by PRIMA-1 and its active metabolite, 2-methylene-3-quinuclidinone hydrate |
|
2014 |
| Resveratrol prevents p53 core domain aggregation |
|
2014 |
| The p53 reactivator PRIMA-1 inhibits p53 aggregation |
|
2014 |
| Does Resveratrol Prevent p53 Aggregation? |
|
2014 |
| A New Mechanism of Action for PRIMA-1 on p53 Reactivation |
|
2013 |
| Structural and Functional Analysis of the Hepatitis C Virus Core Protein |
|
2013 |
| Isolation and Characterization of RNA Molecules Bound to Recombinant Mouse Prion Protein |
|
2013 |
| The tumor suppressor protein p53 is structurally stabilized by a double-stranded DNA thioaptamer and protected from heat and high pressure denaturation |
|
2012 |
| Aggregation of mutant p53 into prion-like amyloid oligomers and fibrils?Implications for cancer |
|
2012 |
| Structural Stabilization of the Tumor Suppressor Protein p53 by a Double- Stranded DNA Thioaptamer |
|
2012 |
| Structural and Thermodynamic Characterization of the Capsid Protein of Hepatitis C Virus and its Interaction with the Tumor Suppressor Protein p53 |
|
2012 |
| Estudo do Processo de Agregação da proteína p53 por Espectroscopia Raman |
|
2012 |
| Structural and Thermodynamic Characterization of the Capsid Protein of Hepatitis C Virus and its Interaction with the Tumor Suppressor Protein p53 |
|
2012 |
| The tumor supressor protein p53 is protected from heat and high pressure denaturation by a double-stranded DNA thioaptamer |
|
2012 |
| Studies on the utilization of a thioaptamer for the rescue of p53 and its mutants |
|
2011 |
| Evaluation of the pathophysiological role of PrP:RNA interaction |
|
2011 |
| Effects of a thioaptamer on the rescue of p53 and its mutants |
|
2011 |
| Putative Role of an ABC transporter on Fonsecaea pedrosoi on Multidrug Resistance |
|
2010 |
| Study of the potential of Triterpens isolated from Lippia Lacunosa to inhibit rhodamine 6G efflux mediated by Pdr5p |
|
2010 |
| Cellular studies with PrP:RNA aggregates |
|
2010 |
| Studies on the utilization of a thioaptamer for the rescue of p53 and its R248Q mutant |
|
2010 |
| Structural and Physiological Aspects of PrP Interaction with RNA Molecules |
|
2010 |
| Effects of different groups of chalcones on ABCG2-overexpressing cells through mitoxantrone accumulation |
|
2009 |
| Oroidin: Activity on Pdr5p, a multidrug resistance protein from Saccharomyces cerevisiae |
|
2009 |
| CYTOTOXICITY OF N-PHENYL MALEIMIDES FOR MELANOMA AND LEUKEMIA CELL LINES AND INHIBITION OF MULTIDRUG RESISTENCE PROTEIN (Pdr5p) |
|
2009 |
| Study of triterpenes isolated from Lippia lacunosa as MDR inhibitors in fungal cells |
|
2009 |
| Análise por LC-PDA-MS e desreplicação de alcalóides bromopirrólicos da esponja Agelas sventres |
|
2008 |
| Compounds isolated from Stachytarpheta cayennensis as inhibitors of Rhodamine 6G efflux in Saccharomyces cerevisiae Pdr5p |
|
2008 |
| Cirsimaritin and a triterpen are potent inhibitors of Pdr5p activity |
|
2008 |
| Effect of marine sponge Agelas sventres on Saccharomyces cerevisiae multidrug resistance protein Pdr5p |
|
2008 |
| PLANT EXTRACTS USED IN BRAZILIAN TRADITIONAL MEDICINE: EFFECT ON PDR5P ATPASE ACTIVITY FROM SACCHAROMYCES CEREVISIAE |
|
2007 |
| EFFECT OF MARINE SPONGES PETROMICA CITRINA AND AGELAS SP.ON SACCHAROMYCES CEREVISIAE MULTIDRUG RESISTANCE PROTEIN PDR5P |
|
2007 |
| INHIBITORY EFFECTS OF GALLIC ACID ESTER DERIVATIVES ON SACCHAROMYCES CEREVISIAE MDR PROTEIN PDR5P |
|
2007 |
| IDENTIFICATION AND CHARACTERIZATION OF ABC TRANSPORTER HOMOLOGOUS TO PDR5P IN PARACOCCIDIOIDES BRASILIENSIS |
|
2007 |
| The effects of Cabralea canjerana ethanolic extract and its fractions on protein Pdr5p catalytic activity: searching for new multidrug resistance reversal agents |
|
2006 |
| Studies on Sacharomyces cerevisiae multidrug protein Pdr5p: inhibition by Lippia lacunosa and Lippia rotundifolia extracts |
|
2006 |
| Effect of marine sponges n Pdr5p catalytic activity of Saccharomyces cerevisae |
|
2006 |
| Efeito do extrato de Cabralea canjerana sobre a proteína Pdr5p |
|
2005 |
| Investigation of the modulatory effects of fractions obtained form the plant extracts of Mabea fistulifera and Bauhinia microstachya var. massambensis on ATPase activity of the yeast multidrug transporter Pdr5p |
|
2005 |
| Studies on yeast multidrug resistance protein Pdr5p: inhibition by Solanum gilo extracts |
|
2005 |
| Effect of Different Plant Extracts on Pdr5p |
|
2004 |
| Efeito de Fitoterápicos sobre a Atividade Enzimática da Pdr5p de Leveduras |
|
2003 |
| Stereochemistry of Lithium Enolates: Claisen-Aldol and Darzens Asymmetric Reactions |
|
2003 |
| Efeito de fitoterápicos sobre a atividade enzimática da Pdr5p de Leveduras |
|
2003 |
| Produção de Arilserinas via Condensação de Mukayama-Kobayashi |
|
2002 |
| Produção Enantiosseletiva de Alfa-amino ácidos: Alquilglicinas N,N-substituídas |
|
2002 |
| On The synthesis of New AntiHIV Compounds |
|
2001 |
| Síntese Assimétrica de Fenilserinas |
|
2001 |
| Preparação Diastereosseletiva de Epóxidos |
|
2000 |
| Perfil Químico e Farmacológico de Bromeliaceae Brasileira |
|
1999 |
